As of May 23
| -1.39 / -0.93%|
The 15 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 175.00, with a high estimate of 200.00 and a low estimate of 137.00. The median estimate represents a +18.04% increase from the last price of 148.25.
The current consensus among 16 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.